A study of ENT symptoms in leprosy patients at a leprosy rehabilitation centre in Hyderabad, Telangana, India

Bhasmitha G. Reddy; Gurpreet Ranjit; Pranav G. V. N. Aditya; Nithin S. Jangam; Vishnu Vardhan M. Reddy; Ananth S. Reddy

doi:10.18203/issn.2454-5929.ijohns20260790

Authors

Bhasmitha G. Reddy Malla Reddy Institute of Medical Sciences, Suraram, Hyderabad, Telangana, India
Gurpreet Ranjit Malla Reddy Institute of Medical Sciences, Suraram, Hyderabad, Telangana, India
Pranav G. V. N. Aditya Malla Reddy Institute of Medical Sciences, Suraram, Hyderabad, Telangana, India
Nithin S. Jangam Malla Reddy Institute of Medical Sciences, Suraram, Hyderabad, Telangana, India
Vishnu Vardhan M. Reddy Department of ENT, Malla Reddy Institute of Medical Sciences, Suraram, Hyderabad, Telangana, India
Ananth S. Reddy Sivananda Rehabilitation Home, Hyderabad, Telangana, India

DOI:

https://doi.org/10.18203/issn.2454-5929.ijohns20260790

Keywords:

Hansen’s disease, Leprosy, Otorhinolaryngology, Nasal manifestations, Epistaxis, Turbinate atrophy, Septal perforation, Multibacillary

Abstract

Background: Hansen’s disease (leprosy) remains endemic in India. Otorhinolaryngologic (ENT) involvement, particularly of the nasal mucosa, may occur early but is often overlooked. Early recognition is vital for timely treatment and prevention of irreversible deformities. The objective was to describe the spectrum and frequency of ENT manifestations among multibacillary leprosy patients at a rehabilitation center in Hyderabad, India.

Methods: A cross-sectional observational study was conducted at Sivananda Rehabilitation Home from September 6-25, 2025. Forty-nine confirmed multibacillary patients (ages 12-70) underwent structured ENT evaluation, including anterior rhinoscopy, otoscopy, and oropharyngeal examination. For disease-type and bacteriological index (BI) correlations, an analytic cohort of 42 patients was used.

Results: In the analytic cohort (n=42), disease distribution was lepromatous (47.6%), borderline lepromatous (40.5%), and mid-borderline (11.9%). Overall, 16/49 (32.7%) reported nasal symptoms, with epistaxis being most common (62.5%). Clinical examination revealed nasal abnormalities in 28/49 (57.1%); turbinate atrophy was most frequent (36.7%), followed by hypertrophy (12.2%) and septal perforation (8.2%). Notably, 75% of patients with septal perforation had a BI>4. No participant reported ear or throat symptoms, though incidental otoscopic findings occurred in 12.2%.

Conclusions: ENT involvement is common in multibacillary leprosy, predominantly affecting the nose. Objective nasal findings significantly outpace reported symptoms. Routine ENT evaluation, specifically focused nasal examination, should be incorporated into standard leprosy assessments to support early recognition and reduce complications.

Metrics

Metrics Loading ...

References

Ghosh S, Chaudhuri S. Chronicles of Gerhard-Henrik Armauer Hansen's Life and Work. Indian J Dermatol. 2015;60(3):219-21. DOI: https://doi.org/10.4103/0019-5154.156310

World Health Organization. Global leprosy (Hansen disease) update, 2020: impact of COVID-19 on global leprosy control. Wkly Epidemiol Rec. 2021;96(36):421-44.

Loscalzo J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison's Principles of Internal Medicine. 21st ed. New York, NY: McGraw Hill; 2022.

Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966;34(3):255-73.

Eichelmann K, González González SE, Salas-Alanis JC, Ocampo-Candiani J. Leprosy. An update: Definition, pathogenesis, classification, diagnosis, and treatment. Actas Dermosifiliogr. 2013;104(7):554-63. DOI: https://doi.org/10.1016/j.adengl.2012.03.028

Huang CL. The transmission of leprosy in man. Int J Lepr Other Mycobact Dis. 1980;48(3):309-18.

Silva GM, Petrocinio LG, Patrocinio JA, Goulart IMB. Otorhinolaryngologic evaluation from leprosy patients’ protocol of a National Reference center. Int Arch Otorhinolaryngol. 2008;12(1):77-81.

Vora DN, Popat VC, Brahmbhatt V. Rhinological evaluation in leprosy. World Articles in Ear, Nose Throat. 2012;5(2):5.

Lalwani AK, Tami TA, Gelber RH. Lepromatous Leprosy: Nasal Manifestations and Treatment with Minocycline. Ann Otol Rhinol Laryngol. 1992;101(3):261-4. DOI: https://doi.org/10.1177/000348949210100310

Camacho ID, Burdick A, Benjamin L, Casiano R. Chronic Rhinitis: A Manifestation of Leprosy. Ear Nose Throat J. 2011;90(9):1-3. DOI: https://doi.org/10.1177/014556131109000915

Khetani A. Nasal Symptoms in Leprosy. J Am Acad Dermatol. 2024;91(3):83. DOI: https://doi.org/10.1016/j.jaad.2024.07.1042

Barton RPE. Clinical manifestations of leprous rhinitis. Lepr Rev. 1974;45(2):135-44.